Biotechnologijų patentavimo prielaidos Lietuvos teisėje

Abstract

The idea of Master finality paperwork is to traverse a prerequisite of biotechnology patenting: novelty, non-obviously, industrial applicability, legality, bailment. With reference of the biotechnology inventions place in the industry property objects system, would be exhibiting the conditions of biotechnology patenting in Lithuanian legalese base. Classical biotechnology may be defined loosely as the production of useful products by living micro-organisms, and as such it has been with us for a long time. Biotechnology has based a whole new industry, and patent protection for biotechnological inventions is of immense commercial importance. But patent law and practice have had serious difficulties in keeping up with the rapid scientitic progress in this field, and issues such as inventive step, sufficiency of disclosure, and permissible breadth of claims have proved trouble-some. The grant of a patent confers a civil right on the patent owner to prevent others from exploiting what is claimed in the patent, excluding use for scientific research purposes. It does not permit the patent owner to exploit his own invention (eg a patent owner must comply with national regulations regarding the use of the invention). The industries that utilise biotechnology are convinced that intellectual property protection should be obtainable for the inventions that stem from research and which have commercial potential. So, this paperwork ground- to give reasons of the rise of biotechnology patenting in Lithuanian law system, to get prescriptive of foreign biotechnology patenting jurisprudence in European and International level, to related finding to the biotechnology patient law of Lithuanian.